Congenital adrenal hyperplasia: management during critical illness

BACKGROUND—Little is known of the optimal dose and administration schedule of hydrocortisone in critically ill patients with congenital adrenal hyperplasia (CAH) caused by 21-hydroxylase deficiency.
AIM—To determine plasma cortisol concentrations after intravenous administration of hydrocortisone in...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Charmandari, E, Lichtarowicz-Kryn..., E, Hindmarsh, P, Johnston, A, Aynsley-Green, A, Brook, C
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BMJ Group 2001
Aiheet:
General and Acute Paediatrics
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC1718849/
https://ncbi.nlm.nih.gov/pubmed/11420193
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/adc.85.1.26
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia